175 related articles for article (PubMed ID: 2180130)
1. Organophosphates and delayed neuropathy--is NTE alive and well?
Johnson MK
Toxicol Appl Pharmacol; 1990 Mar; 102(3):385-99. PubMed ID: 2180130
[TBL] [Abstract][Full Text] [Related]
2. Symposium introduction: retrospect and prospects for neuropathy target esterase (NTE) and the delayed polyneuropathy (OPIDP) induced by some organophosphorus esters.
Johnson MK
Chem Biol Interact; 1993 Jun; 87(1-3):339-46. PubMed ID: 8343991
[TBL] [Abstract][Full Text] [Related]
3. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy.
Lotti M; Moretto A; Capodicasa E; Bertolazzi M; Peraica M; Scapellato ML
Toxicol Appl Pharmacol; 1993 Oct; 122(2):165-71. PubMed ID: 8211998
[TBL] [Abstract][Full Text] [Related]
4. Neuropathy target esterase (NTE) and organophosphorus-induced delayed polyneuropathy (OPIDP): recent advances.
Johnson MK; Glynn P
Toxicol Lett; 1995 Dec; 82-83():459-63. PubMed ID: 8597094
[TBL] [Abstract][Full Text] [Related]
5. Postscript to the symposium on organophosphorus compound induced delayed neuropathy.
Aldridge N
Chem Biol Interact; 1993 Jun; 87(1-3):463-6. PubMed ID: 8344004
[TBL] [Abstract][Full Text] [Related]
6. A mechanism for organophosphate-induced delayed neuropathy.
Glynn P
Toxicol Lett; 2006 Mar; 162(1):94-7. PubMed ID: 16309859
[TBL] [Abstract][Full Text] [Related]
7. The role of neurotoxic esterase (NTE) in the prevention and potentiation of organophosphorus-induced delayed neurotoxicity (OPIDN).
Pope CN; Tanaka D; Padilla S
Chem Biol Interact; 1993 Jun; 87(1-3):395-406. PubMed ID: 8343996
[TBL] [Abstract][Full Text] [Related]
8. In vitro modifications of rat NTE and other esterases by chemicals which induce delayed neurotoxicity in vivo.
Blasco R; Moreno E; Sanz P; Repetto M
Vet Hum Toxicol; 1990 Oct; 32(5):435-9. PubMed ID: 2238440
[TBL] [Abstract][Full Text] [Related]
9. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy.
Milatovic D; Moretto A; Osman KA; Lotti M
Chem Res Toxicol; 1997 Sep; 10(9):1045-8. PubMed ID: 9305588
[TBL] [Abstract][Full Text] [Related]
10. Delayed neuropathy and inhibition of soluble neuropathy target esterase following the administration of organophosphorus compounds to hens.
Tian Y; Xie XK; Piao FY; Yamauchi T
Tohoku J Exp Med; 1998 Jul; 185(3):161-71. PubMed ID: 9823777
[TBL] [Abstract][Full Text] [Related]
11. Reactivity and stereospecificity of neuropathy target esterase and alpha-chymotrypsin with 2-substituted-4H-1,3,2-benzodioxaphosphorin 2-oxides.
Yoshida M; Wu SY; Casida JE
Toxicol Lett; 1994 Nov; 74(2):167-76. PubMed ID: 7940598
[TBL] [Abstract][Full Text] [Related]
12. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride.
Lotti M; Caroldi S; Capodicasa E; Moretto A
Toxicol Appl Pharmacol; 1991 Apr; 108(2):234-41. PubMed ID: 2017753
[TBL] [Abstract][Full Text] [Related]
13. Neuropathy target esterase is required for adult vertebrate axon maintenance.
Read DJ; Li Y; Chao MV; Cavanagh JB; Glynn P
J Neurosci; 2009 Sep; 29(37):11594-600. PubMed ID: 19759306
[TBL] [Abstract][Full Text] [Related]
14. The phosphorothioic acid O-(2-chloro-2,3,3-trifluorocyclobutyl) O-ethyl S-propyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase.
Moretto A; Bertolazzi M; Lotti M
Toxicol Appl Pharmacol; 1994 Nov; 129(1):133-7. PubMed ID: 7974486
[TBL] [Abstract][Full Text] [Related]
15. The R-(+)isomer of O-n-hexyl S-methyl phosphorothioamidate causes delayed neuropathy in hens after generation of a form of inhibited neuropathy target esterase (NTE) which can be reactivated ex vivo.
Johnson MK; Safi JM
Chem Biol Interact; 1993 Jun; 87(1-3):443-8. PubMed ID: 8344001
[TBL] [Abstract][Full Text] [Related]
16. The influence of chirality on the delayed neuropathic potential of some organophosphorus esters: neuropathic and prophylactic effects of stereoisomeric esters of ethyl phenylphosphonic acid (EPN oxon and EPN) correlate with quantities of aged and unaged neuropathy target esterase in vivo.
Johnson MK; Read DJ
Toxicol Appl Pharmacol; 1987 Aug; 90(1):103-15. PubMed ID: 3629585
[TBL] [Abstract][Full Text] [Related]
17. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.
Makhaeva GF; Rudakova EV; Sigolaeva LV; Kurochkin IN; Richardson RJ
J Appl Toxicol; 2016 Nov; 36(11):1468-75. PubMed ID: 26970094
[TBL] [Abstract][Full Text] [Related]
18. High doses of soman protect against organophosphorus-induced delayed polyneuropathy but tabun does not.
Johnson MK; Willems JL; De Bisschop HC; Read DJ; Benschop HP
Toxicol Appl Pharmacol; 1988 Jan; 92(1):34-41. PubMed ID: 3341026
[TBL] [Abstract][Full Text] [Related]
19. Neuronal differentiation of NTE-deficient embryonic stem cells.
Li Z; Szurek PF; Jiang C; Pao A; Bundy B; Le WD; Bradley A; Yu YE
Biochem Biophys Res Commun; 2005 May; 330(4):1103-9. PubMed ID: 15823557
[TBL] [Abstract][Full Text] [Related]
20. Phenyl di-n-pentylphosphinate: a convenient reactivatible inhibitor for studies on neuropathy target esterase (NTE) and protection against organophosphate-induced delayed polyneuropathy.
Johnson MK; Bird I; Meredith C
Toxicol Lett; 1988 Feb; 40(2):133-40. PubMed ID: 2829392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
